Pharmacodynamic evaluation of a new glycopeptide, LY333328, and in vitro activity against Staphylococcus aureus and Enterococcus faecium.

The objectives of the present study were to compare the in vitro activity of LY333328 (LY) to that of vancomycin (V) alone and in combination with gentamicin (G) and rifampin (R) against methicillin-resistant Staphylococcus aureus (MRSA) and V-resistant Enterococcus faecium (VREF), by using the kill...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Mercier, R C, Houlihan, H H, Rybak, M J
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1997
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163905/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9174189/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.41.6.1307
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!